Patent 6951880 was granted and assigned to Genelabs Technologies on October, 2005 by the United States Patent and Trademark Office.
This invention provides novel compounds possessing antibacterial and/or antifungal and/or antitumor activity. Pharmaceutical compositions containing these compounds, methods of making and methods for using these compounds are also provided.